Patients with a p16(+) status in oropharyngeal tumors are less likely to have persistent lymph node metastases in the cervical lymph nodes after chemotherapy and it is thus hypothesized that neck dissection may be avoided [8,28]. The gene discussed is CDKN2A; the disease is neoplasm of oropharynx.